Nikki Love

Programs and Courses Taught

DNP/FNP/ELMSN

N602 (Health Policy) also lead of this course
N606 (Synthesis) also lead of this course 
N619 (Advanced Pathophysiology)
N670 (Family Centered Care)
N671/N671L (Physical assessment and lab)
N672 (Role Advocacy) also lead of this course 
N677 (Advanced Pharmacology)
N675/N675 L (Care of Acute and Episodic Conditions and lab)
N676 (Chronic Conditions)
N678L (Clinical Practicum I)
N679L (Clinical Practicum II)
N680L (Clinical Practicum III)
N702 (Health Policy for DNP)
N705 (Leadership for DNP) also lead of this course 
N720 (Project Conceptualization and design for DNP)
N721 (Advance nursing Practice Residency I for DNP)
N731 (Advanced nursing practice residency II for DNP)
N732 (Advanced Nursing Residency III for DNP)
N773 (Ethics for DNP/FNP) also lead of this course 
N781L (FNP clinical III for DNP/FNP)

About Me

I worked as a dialysis RN in 2009 for a couple of years before I transitioned into family practice (FQHC) once I completed my FNP. I worked for the FQHC for about 8 months before I transitioned into internal medicine. At that practice I also learned the art of botox, fillers and sub-acute care. While working in subacute care I rounded on tracheostomy and ventilator dependent patients and treated many conditions including pneumonia, chronic UTIs and sepsis.

I worked full time at that practice for over a year but then transitioned to Capital Nephrology in 2012. I continued to work part time at the internal medicine practice until 2016

At Capital Nephrology I have several different roles. In the past I rounded on in center dialysis patients. However, I am currently focusing on home hemodialysis as well as peritoneal dialysis (PD) patients and make monthly rounds on about 80 patients in the dialysis unit. I also am the leader of education at our practice and hold monthly meetings educating patients about dialysis and ways to prevent dialysis. I also see pre chronic kidney disease (CKD) patients in the office as well as post-transplant patients. I am currently participating in the comprehensive Kidney Care Contracting (CKCC) care model which aims to improve outcomes while reducing costs. I have also participated in many studies in the past that Capital Nephrology conducted.

While working at SMU I have taught most of the FNP and DNP courses and am also a DNP chair. I am the vice president of Faculty Organization (FO), chair of the Faculty Affairs (FA) committee, co-chair of the University Curriculum Committee (UCC) and a member of the Faculty Org Executive Committee (FOEC). I am also a part of the commencement planning committee, and an application admissions committee member for both FNP online and for the entry level of master’s in nursing (ELMSN) program. I also precept students at Elica Health Centers and at Capital Nephrology. 
 

Education

I graduated from Samuel Merritt University (SMU) with my RN in 2009 and with my MSN-FNP in 2011. I completed my Doctoral of Nursing Practice (DNP) at SMU in 2019. 

Teaching Interests

I really enjoy teaching all of the courses SMU has to offer but I absolutely love teaching the students in person. I love teaching physical assessment in person and love attending intensives that occur every semester. I also have a passion for precepting FNP students both at Elica Healthcare and at Capital Nephrology. 

Scholarly Interests

I enjoy anything related to the kidneys and improving outcomes in the CKD/dialysis population 

Publications

-START-CKD: Strategies Using Darbepoetin alpha to Avoid Transfusion in Chronic  
Kidney Disease
-Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects with Chronic Kidney Disease on Hemodialysis
-A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects with Stage III to V Chronic Kidney Disease Not on Dialysis
-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects with Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
-A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia
-A Randomized, Double-blind, parallel-group, multi-center study to evaluate the efficacy and safety of XXX epoetin alfa vs. US licensed eopetin alfa in the treatment of anemia associated with Chronic Kidney Disease: SANDOZ
 

Professional Affiliations & Memberships

AANP
ANNA

Community Service

I am interested in volunteering in underserved communities 

Honors & Awards

Sigma Theta Tau
100% patient satisfaction score at Capital Nephrology every quarter for the past several years